Cingulate Inc.

NASDAQ (USD): Cingulate Inc. (CING)

Last Price

5.92

Today's Change

-0.10 (1.66%)

Day's Change

5.30 - 6.28

Trading Volume

365,997

Overview

Market Cap

12 Million

Shares Outstanding

2 Million

Avg Volume

3,941,735

Avg Price (50 Days)

5.79

Avg Price (200 Days)

22.37

PE Ratio

-0.02

EPS

-326.40

Earnings Announcement

11-Nov-2024

Previous Close

6.02

Open

6.02

Day's Range

5.3 - 6.2889

Year Range

1.8 - 187.2

Trading Volume

366,128

Price Change Highlight

1 Day Change

-1.66%

5 Day Change

-18.01%

1 Month Change

109.19%

3 Month Change

-31.72%

6 Month Change

-58.89%

Ytd Change

-92.66%

1 Year Change

-95.73%

3 Year Change

-99.45%

5 Year Change

-99.45%

10 Year Change

-99.45%

Max Change

-99.45%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment